Pipeline Previews

By No Comments
Sitavig Innocutis Holdings LLC has announced the introduction into the North American markets of Sitavig® (ACYCLOVIR) 50mg Buccal Tablets, licensed from BioAlliance Pharma. Sitavig (50 mg acyclovir) Muco-Adhesive Buccal Tablet…
Read More